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Summary
Most salivary gland tumors are benign, malignant lesions accounting for 15-30% of the total. The most frequent site 
of salivary gland neoplasms is the parotid gland (80% of all cases). We present a case of malignant fibrohistiocytoma 
with atypical features due to its location (in the parotid region), size and rapid growth. Generally, this type of tumor 
arises in the lower limbs and in the abdomen. When located in the parotid gland, these lesions appear as a firm, slow 
growing and painless mass. Due to the low frequency of such lesions and their clinical behavior, the imaging study 
and fine-needle aspiration biopsy findings tend to diagnose them as pleomorphic adenoma. The definitive diagnosis 
requires microscopic study of the resection piece using immunohistochemical techniques. The treatment of choice is 
surgery, occasionally associated to radiotherapy. The success of treatment is dependent upon complete resection of 
the tumor - long term follow-up being necessary due to the risk of recurrence or distant metastasis.
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Introduction
Malignant fibrohistiocytoma (MFH) is an infrequent 
neoplasm that may arise in any body region, though it 
is generally found in the limbs (particularly the legs) and 
abdomen (retroperitoneum) (1). The term “malignant 
fibrohistiocytoma” was introduced in 1963, in reference to 
tumors composed of histiocytes and fibroblasts. At present, 
these lesions are considered to be a variant of high grade 
sarcoma. (2). MFH tends to develop in the skin in the form 
of small, slow-growing nodules, though its behaviour is 
more aggressive when the lesions are located in deep-lying 
tissues (3). The region of the head and neck is affected in 3% 
of cases (2,4), the nasosinusal tract being the most common 
location (1,2). Involvement of the parotid region has been 
reported in about 17 cases to date (5).
While the histological origin is unclear, it has been 
postulated that the tumor derives from histiocytes that 
morphologically and functionally differentiate to form 
fibroblasts (4).
The present study describes a case of MFH located in the 
region of the parotid gland.
Case Report
An 84-year-old woman presented with a steadily growing, 
firm and painless tumor in the right parotid region. The 
patient had been treated in the Department of Dermato-
logy for actinic keratosis and dermatofibroma of the face 
two years before. The magnetic resonance imaging (MRI) 
and maxillofacial computed tomography (CT) findings 
revealed a nodular lesion in the right parotid gland, with 
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bilateral adenopathies of  nonsignificant size. Puncture 
biopsy showed a hematic background with scant cellula-
rity. Individual cells without atypia were noted, together 
with fusocellular elements. The CT, MRI and cytological 
findings suggested a mixed parotid tumor.
At surgery, a considerable increase in lesion size was ob-
served, with evidence of skin involvement (Figure 1). A 
superficial parotidectomy was performed, with removal 
of the adjacent skin tissue (Figure 2a and 2b).
The histological study showed a fusocellular tumor with 
areas of hyalinization and abundant mitoses, occupying 
the gland and infiltrating the dermis – though without rea-
ching the epidermis. Immunohistochemistry proved posi-
tive for vimentin, HHF-35, and focally for smooth muscle 
actin and S-100 protein. CD117, H-caldesmon, CD68, 
CD34, CD31, CKAE1/A3 and desmin proved negative. On 
the basis of these findings, malignant fibrohistiocytoma 
of the parotid gland was diagnosed (Figure 3).
Following hospital discharge, the patient was referred to 
the Oncology Department for neck radiotherapy (60 Gy 
over the surgical bed). One year after surgery the patient 
remains disease-free.
Discussion
Between 5-20% of all sarcomas are ear, nose and throat 
(ENT) lesions. In this context, rhabdomyosarcoma is the 
most common malignancy, followed by MFH. The latter is 
more frequent in adults and is very rare in early childhood 
(2). Males are more often affected (66%), and the maxi-
mum incidence is in the 50-70 years age range (1,6).
Location in the parotid region is not common; as a result, 
MFH is not usually contemplated in the differential diag-
nosis of parotid disorders. When located in this region, 
MFH tends to manifest as a steadily growing, painless 
mass – though facial paralysis may be observed in some 
cases (7). In clinical practice, it is frequently mistaken 
for pleomorphic adenoma – the definitive diagnosis be-
ing established by studying the surgical piece. This can 
occur with other types of infrequent tumors when they 
are located in this gland, such as solitary fibrous tumors 
(8), basal cell adenoma (9) or sebaceous adenoma (10), 
among others.
Atypical rapid growth was observed in this case, though 
this feature is not unusual (11).
The relapse rate is 16-52%, and is fundamentally determi-
ned by the presence of tumor-positive surgical resection 
margins (2). Initial aggressive surgical management is the-
refore indicated (12). Surgery is the first choice treatment. 
In this case, the absence of facial nerve involvement and 
the characteristics of  tumor resection margins allowed 
preservation of  the nerve. Radiotherapy is considered 
postoperatively, though some authors include malignant 
fibrohistiocytoma as a radioinduced tumor (6). Chemo-
therapy seems to be of scant utility (7)
Distant metastases appear in one-third of cases, involving 
mainly lung, bone and liver. Lymph node involvement is 
less common (6).
Despite its infrequency, MFH should be considered in the 
differential diagnosis of parotid gland tumors, comprising 
rhabdomyosarcoma, leiomyosarcoma, liposarcomas and 
pleomorphic carcinoma, among other lesions. Surgery is the 
management of choice, with or without radiotherapy.
Fig. 1. Right parotid tumor with apparent skin in-
volvement.
Fig. 2. Partial parotidectomy. 2a) Surgical field with resection of an 
affected cutaneous focus (asterisk). 2b) Resection completed with pre-
servation of the facial nerve (arrow).
Fig. 3. Spindle cells arranged in short fascicles and showing 
a storiform pattern, with numerous mitoses. Remnant sali-
vary ducts are present (hematoxylin-eosin, x100).
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